BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Liver, Amniocentesis, Valproic acid, rs3825942, PRKCA, Angiogenesis, Diabetes mellitus)
Bookmark Forward

QuickView for chylomicron remnant clearance (biogroup)


Body Atlas

Most Correlated Tissues

  1. Fetal liver
  2. Liver
  3. Adrenal gland
  4. Fetal lung
  5. Adrenal gland cortex
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Deficiency of triacylglycerol lipase
  2. Acute hepatic failure
  3. Hepatic failure
  4. Liver transplant disorder
  5. Hyperlipoproteinemia
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. sitagliptin
  2. CP 724714
  3. GSK690693
  4. AT 7519
  5. OTS-167
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR20B
  2. LAT
  3. YKT6
  4. PTPN6
  5. FN1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. iPSC as a tool to characterize neuron gene expression profiles in Alzheimer's disease
  2. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
  4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
  5. L1000 CMAP - Pancreatic cancer YAPC.311 cells with CRISPR-targeted gene knockouts
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipop…
  2. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizin…
  3. Old age and the hepatic sinusoid.
  4. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics usin…
  5. Mechanisms of hepatic chylomicron remnant clearance.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous …
  2. Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fa…
  3. DARK STUDY "DysbetalipoproteinemiA and atheRoma Risk"
  4. Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons
  5. In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.